论文部分内容阅读
目的目的对比分析阿奇霉素与红霉素对小儿支原体肺炎(MP)的疗效情况。方法法选择我院84例MP患儿,按照治疗方法将其分为两组,即阿奇霉素组及红霉素组,各42例;比较两组临床疗效及不良反应发生率。结果阿奇霉素组临床总有效率达97.62%,明显高于红霉素组78.57%(P<0.05)。阿奇霉素组不良反应发生率仅为4.76%,明显低于红霉素组19.05%(P<0.05)。结论应用阿奇霉素治疗MP不仅疗效好,而且安全性高。
Objective To compare the effects of azithromycin and erythromycin on children with mycoplasma pneumonia (MP). METHODS: Eighty-four cases of MP in our hospital were divided into two groups according to the treatment method, namely, azithromycin group and erythromycin group, with 42 cases in each group. The clinical efficacy and the incidence of adverse reactions were compared between the two groups. Results The total effective rate of azithromycin group was 97.62%, which was significantly higher than that of erythromycin group (78.57%, P <0.05). The incidence of adverse reactions in azithromycin group was only 4.76%, which was significantly lower than that in erythromycin group (19.05%, P <0.05). Conclusion The application of azithromycin MP is not only effective, but also safe.